Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Charles River Laboratories has acquired Blue Stream Laboratories, Inc. Combining Blue Stream with Charles River’s existing discovery, safety assessment, and biologics capabilities creates a leading provider with the ability to support biologic and ...
read more
Emergent BioSolutions has announced that its Center for Innovation in Advanced Developmentand Manufacturing (CIADM) has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $21.9 million to ...
read more
Sharp Packaging Solutions has increased its packaging capacity by 30% for its life science customers with a $45 million investment in a new Center of Excellence for specialty/biologic/cold chain packaging on Penn Am Drive, Allentown and in the ...
read more
Envigo has announced that its Board of Directors has appointed Dr Adrian Hardy as President and Chief Executive Officer, effective 1 July 2016, and that he will join the Company’s Board of Directors. Dr Hardy joined Envigo in 2002 and has held ...
read more
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has agreed, subject to certain customary closing conditions (including applicable regulatory approvals), to ...
read more
Catalent Pharma Solutions, has reached a commercial supply agreement with Palatin Technologies, Inc., to support the global commercial product launch of Palatin’s bremelanotide pen injector product, which is used to treat female sexual dysfunction (...
read more
Mayne Pharma has entered into a binding agreement to acquire a portfolio of U.S. generic products from Teva and Allergan for cash consideration of $652 million. The portfolio consists of 37 approved products and 5 FDA filed products in attractive ...
read more
MEDIAN Technologies, a medical imaging software developer and service provider for image interpretation and management in oncology clinical trials, has announced the expansion of the company's relationship with START, a global Phase I oncology ...
read more
BlueTheory Clinical Trials, a clinical research network company headquartered in Boston, Massachusetts has been partnering with pharmaceutical and contract research organizations (CROs) to bring treatments and devices to the market since its ...
read more
Veeva Systems and Kinapse Ltd., a provider of life sciences advisory and operational services, announced that Kinapse has selected Veeva Vault Submissions to power its new regulatory operational services.
read more
Pharm-Olam International Ltd., a multinational, full-service Clinical Research Organization (CRO), serving the biopharmaceutical and medical device industries, announces the appointment of Fabiola Encinas as the Country Operations Manager for Mexico.
read more
Teewinot Life Sciences Corporation and Albany Molecular Research, Inc. (AMRI) have announced that AMRI licensed Teewinot's technology to produce and sell the first commercially available cannabichromene acid (CBCA) analytical standard. The CBCA ...
read more
Quintiles has announced the launch of its new Continuous Glucose Monitoring (CGM) service offering. This new solution combines innovative, wearable technology with Quintiles’ deep therapeutic and analytical expertise to help enhance the efficiency ...
read more
Pfizer has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net in cash (without interest but subject to ...
read more
HealthCore, Inc. will collaborate with PCORnet, the National Patient-Centered Clinical Research Network, on building a sustainable patient-centered outcomes research network to conduct real-world comparative effectiveness research as part of a ...
read more